After 24 h, CLRP significantly increased the levels of CML and RAGE; however, LL-KF140 strongly inhibited these CLRP-mediated increases (p < 0.05 and p < 0.01, respectively). This evidence concerns the gene NYX and chronic myelogenous leukemia, BCR-ABL1 positive.